Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens?Velia Chiara Di Maio, L. Lambiase, Maurizio Zazzi et al.|Journal of Hepatology|2017Cited by 31
Ambulatory blood pressure monitoring in the elderly: Features and perspectivesFabio Angeli, Gianpaolo Reboldi, Paolo Verdecchia et al.|Nutrition Metabolism and Cardiovascular Diseases|2014Cited by 8
Multiclass hepatitis C virus resistance to direct acting antivirals in real life interferon-free regimens failures advocates for tailored second-line therapiesVelia Chiara Di Maio, M. Paoloni, Valeria Cento et al.|Journal of Hepatology|2017Cited by 2
Multiclass HCV resistance to interferon-free direct acting antivirals regimens in real life failures advocates for tailored second-line therapiesVelia Chiara Di Maio, Valeria Pace Palitti, Valeria Cento et al.|Digestive and Liver Disease|2017Cited by 1